Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension

Mitsushige Murata, Takashi Kawakami, Masaharu Kataoka, Takashi Kohno, Yuji Itabashi, Keiichi Fukuda

研究成果: Letter

4 引用 （Scopus）

抜粋

Riociguat is a soluble guanylate cyclase stimulator used for pulmonary hypertension (PH) treatment. We evaluated right ventricular (RV) contractile function in 27 PH patients receiving riociguat. A comparison of pre- and post-administration echocardiographic studies demonstrated significantly improved RV strain after riociguat treatment, even after adjusting for RV afterload.

元の言語English
ジャーナルPulmonary Circulation
巻8
発行部数1
DOI
出版物ステータスPublished - 2018 1 1

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

文献にアクセス

フィンガープリント Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

    • これを引用